Kroll H, Salama A, Berghöfer H, Ernst-Schlegel M, Mueller-Eckhardt C
Institut für Klinische Immunologie und Transfusionsmedizin, Justus-Liebig-Universität Giessen, BRD.
Beitr Infusionsther. 1993;31:162-7.
Drug-induced immune hemolytic anemia is a serious hematological disorder which results from increased red blood cell destruction due to the production of autoantibodies, drug (metabolite)-dependent antibodies (DDAb) or both types of antibodies, even in one patient by the same drug. One of the major problems related to DDAb is that the causative drug (metabolite) usually does not bind tightly to target cells, and the antibodies are completely removed from the cells by conventional washing procedures, i.e. by the antiglobulin test. We have recently shown that the microtube geltest, by which the antiglobulin test is performed without washing the cells, is a highly sensitive and reliable alternative method for the detection of all kinds of DDAb. The results obtained with different DDAb are discussed.
药物性免疫性溶血性贫血是一种严重的血液系统疾病,它是由于自身抗体、药物(代谢产物)依赖性抗体(DDAb)或这两种抗体的产生导致红细胞破坏增加引起的,即使是同一药物作用于同一患者。与DDAb相关的主要问题之一是致病药物(代谢产物)通常不紧密结合靶细胞,并且通过常规洗涤程序(即抗球蛋白试验)可将抗体完全从细胞中去除。我们最近表明,微管凝胶试验(一种不洗涤细胞即可进行抗球蛋白试验的方法)是检测各类DDAb的一种高度灵敏且可靠的替代方法。文中讨论了不同DDAb的检测结果。